Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (4) , 563-580
- https://doi.org/10.1016/j.clinthera.2007.03.018
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patientsJournal of Human Hypertension, 2007
- Long-term adherence with cardiovascular drug regimensAmerican Heart Journal, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005
- The Burden of Adult Hypertension in the United States 1999 to 2000Hypertension, 2004
- Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) studyClinical Therapeutics, 2004
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Rationale for Fixed-Dose Combinations in the Treatment of HypertensionDrugs, 2002
- Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placeboClinical Therapeutics, 1996